AMGEN INC logo

AMGEN INC

AMGN
Biological Products No Disgnostic Substances
Last filing · Quarter 2 · Jun 30, 2026
Order
RatiosJun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jun 30, 2012Mar 31, 2012Sep 30, 2011Jun 30, 2011Mar 31, 2011Sep 30, 2010Jun 30, 2010Mar 31, 2010Sep 30, 2009Jun 30, 2009
Gross Margin
72.04%
68.16%
67.75%
67.20%
63.58%
61.07%
61.42%
57.03%
73.84%
74.05%
71.83%
76.13%
Operating Margin
34.95%
30.94%
26.43%
28.94%
14.46%
24.07%
22.76%
13.31%
29.28%
38.42%
31.47%
39.99%
Pretax Margin
27.53%
24.18%
41.03%
17.08%
24.21%
36.47%
9.47%
-0.91%
28.21%
23.10%
56.38%
35.96%
Effective Tax Rate
14.20%
12.72%
17.98%
8.67%
12.32%
8.74%
6.05%
-66.18%
11.15%
14.56%
17.46%
10.41%
Net Margin
23.62%
21.11%
33.65%
15.60%
21.23%
33.28%
8.89%
-1.52%
25.06%
19.74%
46.54%
32.22%
Current Ratio
1.37x
1.26x
1.28x
1.31x
1.17x
1.32x
1.26x
1.42x
2.86x
2.77x
3.14x
1.68x
Debt to Equity
7.18x
9.07x
8.37x
10.83x
13.40x
11.07x
14.34x
17.51x
10.83x
12.31x
15.59x
16.44x
Net Debt to Equity
5.99x
7.76x
7.39x
9.75x
11.98x
9.88x
12.77x
15.58x
6.29x
7.26x
9.69x
13.84x
Asset Turnover
10.51%
9.32%
10.60%
10.44%
9.12%
9.36%
9.23%
8.01%
7.62%
7.74%
6.88%
10.44%
Return on Equity
20.32%
19.79%
33.43%
19.28%
27.87%
37.60%
12.59%
-2.25%
22.60%
20.34%
53.12%
58.66%
Return on Assets
2.48%
1.97%
3.57%
1.63%
1.94%
3.11%
0.82%
-0.12%
1.91%
1.53%
3.20%
3.36%